Andy Chen

Stock Analyst at Wolfe Research

(2.25)
# 2,659
Out of 4,893 analysts
39
Total ratings
44.44%
Success rate
-0.05%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andy Chen

Verona Pharma
Jul 1, 2025
Initiates: Outperform
Price Target: $170
Current: $104.77
Upside: +62.26%
BridgeBio Pharma
Jun 17, 2025
Initiates: Outperform
Price Target: $49
Current: $45.98
Upside: +6.57%
Sarepta Therapeutics
Jun 17, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $19.37
Upside: -
Avidity Biosciences
Jun 17, 2025
Initiates: Outperform
Price Target: $55
Current: $31.27
Upside: +75.89%
Blueprint Medicines
Jun 3, 2025
Downgrades: Peer Perform
Price Target: n/a
Current: $128.55
Upside: -
MoonLake Immunotherapeutics
May 19, 2025
Upgrades: Outperform
Price Target: $61
Current: $48.28
Upside: +26.35%
Intellia Therapeutics
Apr 21, 2025
Upgrades: Outperform
Price Target: $21
Current: $12.13
Upside: +73.12%
AnaptysBio
Feb 4, 2025
Initiates: Outperform
Price Target: n/a
Current: $25.74
Upside: -
Crinetics Pharmaceuticals
Feb 4, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $32.33
Upside: -
89bio
Feb 4, 2025
Initiates: Outperform
Price Target: n/a
Current: $10.57
Upside: -
Initiates: Outperform
Price Target: $20
Current: $14.23
Upside: +40.55%
Initiates: Outperform
Price Target: $49
Current: $24.21
Upside: +102.40%
Initiates: Outperform
Price Target: $19
Current: $10.49
Upside: +81.12%
Downgrades: Peer Perform
Price Target: n/a
Current: $17.29
Upside: -
Upgrades: Outperform
Price Target: $697
Current: $555.19
Upside: +25.54%
Downgrades: Underperform
Price Target: n/a
Current: $320.87
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $68.72
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $22.46
Upside: -
Upgrades: Outperform
Price Target: $65
Current: $45.18
Upside: +43.87%
Initiates: Outperform
Price Target: n/a
Current: $51.13
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $308.59
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $17.04
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $8.44
Upside: -
Upgrades: Outperform
Price Target: n/a
Current: $42.83
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $60.08
Upside: -
Initiates: Outperform
Price Target: $17
Current: $11.22
Upside: +51.52%
Initiates: Outperform
Price Target: n/a
Current: $478.97
Upside: -
Initiates: Outperform
Price Target: $42
Current: $96.47
Upside: -56.46%